$982,669,952 in Total Settlement Funds Available. See if you qualify!Find Out More

Akari Therapeutics, Plc Settlement
(NASDAQ: AKTX)
Settlement

Claim Deadline: October 15, 2018

Settlement Fund: $2,700,000

Settlement Class

All persons or entities that purchased the publicly-traded securities listed on United States stock exchanges of Akari  Therapeutics, plc (“Akari” or the “Company”) during the period from April 24, 2017 through May 30,  2017, both dates inclusive

Important Documents

Settlement Status

Disbursed

Class Period

April 23, 2017 - August 25, 2017

Settlement Hearing Date

November 28, 2018

Opt-Out Deadline

November 07, 2018

Claims Admin

Strategic Claims Services
Akari Therapeutics, plc. Securities Litigation
c/o Strategic Claims Services
P.O. Box 230
600 N. Jackson St., Ste. 205
Media, PA 19063
+1 866-274-4004
info@strategicclaims.net

Levi & Korsinsky did not act as lead counsel or otherwise participate in litigating the above class action and provides this information to remind class members of the deadline to submit a claim for a share of any of the settlement fund.